Skip to main content

Advertisement

Log in

Sestamibi technetium-99m brain single-photon emission computed tomography to identify recurrent glioma in adults: 201 studies

  • Clinical-Patient Studies
  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Summary

Object

In the follow-up of treated gliomas, CT and MRI can often not differentiate radionecrosis from recurrent tumor. The aim of this study was to assess the interest of functional imaging with 99mTc-MIBI SPECT in a large series of 201 examinations.

Method

MIBI SPECT were performed in 81 patients treated for brain gliomas. A MIBI uptake index was computed as the ratio of counts in the lesion to counts in the controlateral region. SPECT was compared to stereotactic biopsy in 14 cases, or in the others cases to imaging evolution or clinical course at 6 months after the last tomoscintigraphy

Two hundred and one tomoscintigraphies were performed. One hundred and two scans were true positive, 82 scans were true negative. Six scans were false positive (corresponding to 3 patients): 2 patients with an inflammatory reaction after radiosurgery, 1 with no explanation up to now. Eleven scans were false negative (5 patients): 1 patient with a deep peri-ventricular lesion, 2 patients with no contrast enhancement on MRI, 2 patients with a temporal tumor. The sensitivity for tumor recurrence was 90%, specificity 91.5% and accuracy 90.5%. We studied separately low and high grade glioma: sensitivity for tumor recurrence was respectively 91% and 89%, specificity 100% and 83% and accuracy 95% and 87%. MIBI SPECT allowed the diagnose of anaplasic degenerence of low grade sometimes earlier than clinical (5 cases) or MRI signs (7 cases).

Conclusions

Our results confirm the usefullness of MIBI SPECT in the follow-up of treated gliomas for the differential diagnosis between radiation necrosis and tumor recurrence.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Black K, Hawkins R, Kim K, Becker D, Lerner C, Marciano D, Use of thallium-201 SPECT to quantitate malignancy grade of gliomas J Neurosurg 71:342–346, 1989

    PubMed  CAS  Google Scholar 

  2. Oriuchi N, Tamura M, Shibazaki T,Ohye C, Watanabe N, Tateno M, Tomiyoshi K, et al. Clinical evaluation of Thallim-201 SPECT in supratentorial gliomas: relationship to histologic grade, prognosis and proliferative activities J Nucl Med 34:2085–2089, 1993

    PubMed  CAS  Google Scholar 

  3. Sasaki M, Kuwabara Y, Yoshiba T, akagawa M, Fukumura T, Mihara F, Morioka T, et al. A comparative study of thallium-201 SPET, carbon-11 methionine PET and fluorine-18 fluorodeoxyglucose PET for the differentiation of astrocytic tumours Eur J Nucl Med 25:1261–1269, 1998

    Article  PubMed  CAS  Google Scholar 

  4. Slizofski WJ, Krishna L, Katsetos C, Black P, Miyamoto C, Brown SJ, Vender J, et al. Thallium imaging for brain tumors with results measured by a semiquantitative index and correlated with histopathology Cancer 74:3190–3197, 1994

    Article  PubMed  CAS  Google Scholar 

  5. Zhang J, Kim S, Andrews D, Intenzo CM, Comparative assessment of four different Tl-201 tumor uptake indices in the evaluation of brain tumors Clin Nucl Med 23:691–694, 1998

    Article  PubMed  CAS  Google Scholar 

  6. Bedar JB, Samnick S, Moringlane JR, Feiden W, Schaefer A, Kremp S, Kirsch CM, Evaluation of L-3-[123I]iodo-α-methyltyrosine SPET and [18F]fluorodeoxyglucose PET in the detection and grading of recurrences in patients pretreated for gliomas at follow-up: a comparative study with stereotactic biopsy Eur J Nucl Med 26: 144–151, 1999

    Article  Google Scholar 

  7. Coleman RE, Hoffman JM, Hanson MW, Sostman HD, Schold SC, Clinical application of PET for the evaluation of brain tumors J Nucl Med 32:616–622, 1991

    PubMed  CAS  Google Scholar 

  8. Di Chiro G, Delapaz R, Brooks R, Sokolof L, Kornblith P, Smith B, Patronas N, et al. Glucose utilization of cerebral gliomas measured by [18 F] fluorodeoxyglucose and positron emission tomography Neurology 32:1323–1329, 1982

    PubMed  CAS  Google Scholar 

  9. Di Chiro G, Oldfield E, Wright D, Katz DA, PET, CT and NMR of cerebral necrosis following radiotherapy or intra-arterial chemotherapy for cerebral tumors AJNR 6:473–474. 1985

    Google Scholar 

  10. Di Chiro G, Oldfield E, Wright D, De Michele D, Katz D, Patronas N, Doppman J, et al.: Cerebral necrosis after radiotherapy and/or intra-arterial chemotherapy

  11. Patronas N, Di Chiro G, Brooks R, DeLaPaz R, Kornblith P, Smith B, Rizzoli H, et al. Work in progress: fluorodeoxyglucose and positron emission tomography in the evaluation of radiation necrosis of the brain Radiology 144:885–889, 1982

    PubMed  CAS  Google Scholar 

  12. Derlon JM, Bourdet C, Bustany P, Chatel M, Theron J, Darcel F, Syrota A, [11 C]-L-Methionine uptake in gliomas Neurosurgery 25:720–728, 1989

    Article  PubMed  CAS  Google Scholar 

  13. Derlon JM, Petit-Taboue MC, Chapon F, Beaudouin V, Noël MH, Creveuil C, Courtheoux P, et al. The in vivo-metabolic pattern of low-grade brain gliomas: a positron emission tomographic study using 18 F-fluorodeoxyglucose and 11 C-L-methylmethionine Neurosurgery 40:276–288, 1997

    Article  PubMed  CAS  Google Scholar 

  14. Thiel A, Pietrzyk U, Sturm V, Herholz K, Hövels M, Schröder R, Enhanced accuracy in differential diagnosis of radiation necrosis by positron emission tomography-magnetic resonance imaging coregistration: technical case report Neurosurgery 1:232–234, 2000

    Article  Google Scholar 

  15. Arbab A, Koizumi K, Toyama K, Araki T, Uptake of Technetium-99 m-Tetrofosmin, Technetium-99 m-MIBI and Thallium-201 in tumor cell lines J Nucl Med 37:1551–1556, 1996

    PubMed  CAS  Google Scholar 

  16. Maublant JC, Zhang Z, Rapp M, Ollier M, Michelot J, Veyre A, In vitro uptake of Technetium-99 m-Teboroxime in carcinoma cell lines and normals cells: comparison with Technetium-99 m-Sestamibi and Thallium-201 J Nucl Med 34:1949–1952, 1993

    PubMed  CAS  Google Scholar 

  17. Piwnica- Worms D, Kronauge JF, Chiu ML, Uptake and retention of hexakis (2-methoxyisobutyl isonitrile) technetium (I) in cultured chick myocardial cells: mitochondrial and plasma membrane potential dependance Circulation 82:1826–1838, 1990

    PubMed  CAS  Google Scholar 

  18. Piwnica- Worms D, Kronauge JF, Delmon L, Holman BL, Marsh JD, Jones AG, Effect of metabolic inhibition on Technetium-99 m-MIBI kinetics in cultured chick myocardial cells J Nucl Med 31:464–472, 1990

    PubMed  CAS  Google Scholar 

  19. Daumas-Duport C, Scheithauer B, O’Fallon J, Kelly P, Grading of astrocytomas: a simple and reproductible method Cancer 62: 2152–2165, 1988

    Article  PubMed  CAS  Google Scholar 

  20. Daumas-Duport C, Varlet P, Tucker ML, Beuvon F, Cevera P, Chodkiewicz JP, Oligodendrogliomas. Part I: Patterns of growth, histological diagnosis, clinical and imaging correlations: a study of 153 cases J Neuro-Oncol 34:37–59, 1997

    Article  CAS  Google Scholar 

  21. Daumas-Duport C, Tucker ML, Kolles H, Cervera P, Beuvon F, Varlet P, Udo N, et al. Oligodendrogliomas. Part II: A new grading system based on morphological and imaging criteria J Neuro-Oncol 34: 61–78, 1997

    Article  CAS  Google Scholar 

  22. Stokely EM, Sveinsdottir E, Lassen NA, Rommer P, A single photon dynamic computer assisted tomograph (DCAT) for imaging brain function in multiple cross sections J Comput Assist Tomogr 4: 230–240, 1980

    Article  PubMed  CAS  Google Scholar 

  23. Lamy-Lhuillier C, Dubois F, Blond S, Lecouffe P, Steinling M Intérêt de la tomoscintigraphie cérébrale au sestamibi marqué au technétium dans le diagnostic différentiel récidive tumorale-radionécrose des tumeurs gliales sus-tentorielles de l’adulte. Neurochirurgie 45:110–117, 1999

    Google Scholar 

  24. Cairncross JG, Pexman JH, Rathbone M, DelMaestro RF, Postoperative contrast enhancement in patients with brain tumor. Ann Neurol 17: 570–572, 1985

    Article  PubMed  CAS  Google Scholar 

  25. Dooms G, Hecht S, Brant-Zawadzki M, Berthiaume Y, Norman D, Newton TH, Brain radiation lesions: MR imaging Radiology 158:149–155, 1986

    PubMed  CAS  Google Scholar 

  26. Dean BL, Drayer BP, Bird CR, Flom RA, Hodak JA, Coons SW, Carey RG, Gliomas: classification with MR imaging Radiology 174:411–415, 1990

    PubMed  CAS  Google Scholar 

  27. Earnest F, Kelly P, Scheithauer BW, Kall BA, Cascino TL, Ehman RL, Forbes GS, et al. Cerebral astrocytomas: Histipathologic correlation of MR and CT contrast enhancement with stereotactic biopsy Radiology 166:823–827, 1988

    PubMed  Google Scholar 

  28. Borodin OYU, Velichko OB, Garganeev AB, Riannel JU, Barisheva EV, Krivonogov NG, Ussov W.: Comparaison of 99 mTc-MIBI SPECT and GD-enhanced MRI in detection of recurrent tumor in malignant gliomas. EANM Congress Paris 2000. Eur J Nucl Med 2000

  29. Ambrus E, Pavics L, Grünwald F, Barath B, Tiszlavicz L, Bender H, Menzel C, et al. 99 mTc-MIBI-SPECT-studies in the evaluation of brain tumors Radiologia diagnostica 35:299–302, 1994

    Google Scholar 

  30. Kahn D, Follett K, Bushnell D, Nathan MA, Piper JG, Madsen M, Kirchner PT, Diagnosis of recurrent brain tumor:value of 201-Tl vs 18 F-fluorodeoxyglucose PET AJR. 163:1459–1465, 1994

    PubMed  CAS  Google Scholar 

  31. Lorberboym M, Baram J, Feibel M, Hercbergs A, Lieberman L, A prospective evaluation of thallium-201 single photon emission computerized tomography for brain tumor burden Int J Rad Oncol Biol Phys 32:249–254, 1995

    Article  CAS  Google Scholar 

  32. Bagni B, Pinna L, Tamarozzi R, Cattaruzzi E, Marzola MC, Bagni I, Ceruti S, et al. SPET imaging of intracranial tumors with Tc99 m sestamibi Nucl Med Comm 16:258–264, 1995

    Article  CAS  Google Scholar 

  33. Baillet G, Albuquerque L, Chen Q, poisson M, Delattre JY, Evaluation of single photon emission tomography imaging of supratentorial brain gliomas with technetium-99 m sestamibi Eur J Nucl Med 21:1061–1066, 1994

    Article  PubMed  CAS  Google Scholar 

  34. Maffioli L, Gasparini M, Chiti A, Gramaglia A, Mongioj V, pozzi A, Bombardieri E, Clinical role of technetium-99 m sestamibi single-photon emission tomography in evaluating pretreated patients with brain tumours Eur J Nucl Med 23:308–311, 1996

    Article  PubMed  CAS  Google Scholar 

  35. O’Tuama LA, Treves S, Larar J, Packard AB, Kwan AJ, Barnes PD, Scott RM, et al. Thallim-201 versus Technetium-99 m-MIBI SPECT in evaluation of childhood brain tumors: a within subject comparison J Nucl Med 34:1045–1051, 1993

    PubMed  CAS  Google Scholar 

  36. Beauchesne P, Soler C, Maatougui K, Schmitt T, Barral FG, Michel D, Dubois F, et al. La tomoscintigraphie cérébrale au 99 mTc-MIBI est-elle utile au diagnostic de récidive locale chez les patients atteints de gliomes malins? Cancer/Radiother 2:42–48, 1998

    Article  CAS  Google Scholar 

  37. Park C, Kim S, Zhang J, Intenzo CM, McEwan JR, Tc-99 m MIBI brain SPECT in the diagnosis of recurrent glioma Clin Nucl Med 19:57–58, 1994

    Article  PubMed  CAS  Google Scholar 

  38. Soler C, Beauchesne P, Maatougui K, Schmitt T, Barral FG, Michel D, Dubois F, et al. Technetium 99 m sestamibi brain single photon emission tomography for detection of recurrent gliomas after radiation therapy Eur J Nucl Med 25:1649–1657, 1998

    Article  PubMed  CAS  Google Scholar 

  39. Kostakaglu L, Elahi N, Kïratli P, Clinical validation of the influence of P-glycoprotein on technetium-99 m-sestamibi uptake in malignant tumors J Nucl Med 38: 1003–1008, 1997

    Google Scholar 

  40. Nabors MW, Griffin CA, Zehnbauer BA, Hruban RH, Phillips PC, Grossman SA, et al. Multidrug resistance gene (MDR1) expression in human brain tumors J Neurosurg 75:941–946, 1991

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Florence Prigent –Le Jeune.

Additional information

Address for offprints: Florence Prigent –Le Jeune, Service de Médecine Nucléaire Centre Eugène Marquis Boulevard de la Bataille Flandres-Dunkerque BP 6279 35062 RENNES cedex France; Fax: +2-99-25-32-60; E-mail: prigent@rennes.fnclcc.fr

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jeune, F.P.–., Dubois, F., Blond, S. et al. Sestamibi technetium-99m brain single-photon emission computed tomography to identify recurrent glioma in adults: 201 studies. J Neurooncol 77, 177–183 (2006). https://doi.org/10.1007/s11060-005-9018-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11060-005-9018-8

Keywords

Navigation